Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Rosiglitazone attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal ischemia in rats.

Zhang FH, Lin YH, Huang HG, Sun JZ, Wen SQ, Lou M.

Neuroscience. 2013 Oct 10;250:651-7. doi: 10.1016/j.neuroscience.2013.07.039. Epub 2013 Jul 25.

PMID:
23892005
2.

Effects of deferoxamine on brain injury after transient focal cerebral ischemia in rats with hyperglycemia.

Xing Y, Hua Y, Keep RF, Xi G.

Brain Res. 2009 Sep 29;1291:113-21. doi: 10.1016/j.brainres.2009.07.032. Epub 2009 Jul 23.

3.

Hemorrhagic transformation induced by acute hyperglycemia in a rat model of transient focal ischemia.

Xing Y, Jiang X, Yang Y, Xi G.

Acta Neurochir Suppl. 2011;111:49-54. doi: 10.1007/978-3-7091-0693-8_9.

PMID:
21725731
4.

Suppression of hypoxia-inducible factor-1alpha and its downstream genes reduces acute hyperglycemia-enhanced hemorrhagic transformation in a rat model of cerebral ischemia.

Chen C, Ostrowski RP, Zhou C, Tang J, Zhang JH.

J Neurosci Res. 2010 Jul;88(9):2046-55. doi: 10.1002/jnr.22361.

PMID:
20155812
5.

Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia.

Qin Z, Karabiyikoglu M, Hua Y, Silbergleit R, He Y, Keep RF, Xi G.

Stroke. 2007 Apr;38(4):1362-7. Epub 2007 Feb 22.

6.

Docosahexaenoic acid attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal cerebral ischemia in rats.

Lin Y, Xu M, Wan J, Wen S, Sun J, Zhao H, Lou M.

Neuroscience. 2015 Aug 20;301:471-9. doi: 10.1016/j.neuroscience.2015.06.024. Epub 2015 Jun 20.

PMID:
26102005
7.

Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.

Copin JC, Gasche Y.

Brain Res. 2008 Dec 3;1243:161-6. doi: 10.1016/j.brainres.2008.09.025. Epub 2008 Sep 19.

PMID:
18835259
8.

Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.

Culman J, Nguyen-Ngoc M, Glatz T, Gohlke P, Herdegen T, Zhao Y.

Exp Neurol. 2012 Dec;238(2):243-53. doi: 10.1016/j.expneurol.2012.09.003. Epub 2012 Sep 17.

PMID:
22995601
9.

Hyperbaric oxygen preconditioning attenuates hyperglycemia-enhanced hemorrhagic transformation by inhibiting matrix metalloproteinases in focal cerebral ischemia in rats.

Soejima Y, Hu Q, Krafft PR, Fujii M, Tang J, Zhang JH.

Exp Neurol. 2013 Sep;247:737-43. doi: 10.1016/j.expneurol.2013.03.019. Epub 2013 Mar 26.

10.

TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.

Cai Y, Liu X, Chen W, Wang Z, Xu G, Zeng Y, Ma Y.

Exp Neurol. 2015 Apr;266:120-6. doi: 10.1016/j.expneurol.2015.02.013. Epub 2015 Feb 20.

PMID:
25708985
12.

Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.

Murakami K, Suzuki M, Suzuki N, Hamajo K, Tsukamoto T, Shimojo M.

Brain Res. 2013 Aug 14;1526:84-93. doi: 10.1016/j.brainres.2013.06.014. Epub 2013 Jun 20.

PMID:
23791950
13.

Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia.

Okamura K, Tsubokawa T, Johshita H, Miyazaki H, Shiokawa Y.

Neurol Res. 2014 Jan;36(1):65-9. doi: 10.1179/1743132813Y.0000000259. Epub 2013 Dec 6.

PMID:
24074041
14.

Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation.

Huang YC, Tzeng WS, Wang CC, Cheng BC, Chang YK, Chen HH, Lin PC, Huang TY, Chuang TJ, Lin JW, Chang CP.

Magn Reson Imaging. 2013 Sep;31(7):1174-81. doi: 10.1016/j.mri.2013.03.026. Epub 2013 May 1.

PMID:
23642800
15.

Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model.

Chen CH, Manaenko A, Zhan Y, Liu WW, Ostrowki RP, Tang J, Zhang JH.

Neuroscience. 2010 Aug 11;169(1):402-14. doi: 10.1016/j.neuroscience.2010.04.043. Epub 2010 Apr 25.

16.

Isoflurane enhanced hemorrhagic transformation by impairing antioxidant enzymes in hyperglycemic rats with middle cerebral artery occlusion.

Hu Q, Ma Q, Zhan Y, He Z, Tang J, Zhou C, Zhang J.

Stroke. 2011 Jun;42(6):1750-6. doi: 10.1161/STROKEAHA.110.603142. Epub 2011 Apr 7.

17.

Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia.

Chu K, Lee ST, Koo JS, Jung KH, Kim EH, Sinn DI, Kim JM, Ko SY, Kim SJ, Song EC, Kim M, Roh JK.

Brain Res. 2006 Jun 6;1093(1):208-18. Epub 2006 May 11.

PMID:
16696956
18.

Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.

Hung YC, Chen TY, Lee EJ, Chen WL, Huang SY, Lee WT, Lee MY, Chen HY, Wu TS.

J Pineal Res. 2008 Nov;45(4):459-67. doi: 10.1111/j.1600-079X.2008.00617.x. Epub 2008 Jul 2.

PMID:
18624955
19.

Hyperglycemia and hemorrhagic transformation of cerebral infarction: a macroscopic hemorrhagic transformation rat model.

Tsubokawa T, Joshita H, Shiokawa Y, Miyazaki H.

Acta Neurochir Suppl. 2011;111:43-8. doi: 10.1007/978-3-7091-0693-8_8.

PMID:
21725730
20.

Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats.

Wang CX, Ding X, Noor R, Pegg C, He C, Shuaib A.

J Cereb Blood Flow Metab. 2009 Oct;29(10):1683-94. doi: 10.1038/jcbfm.2009.87. Epub 2009 Jun 24.

PMID:
19553906

Supplemental Content

Support Center